Regulations Tighten on UK E-Cigarette Market

Apr.26.2023
Regulations Tighten on UK E-Cigarette Market
Recent negative news on UK's disposable e-cigarette market. Testing found 73% of e-liquid capacity exceeded standards and products were unregistered.

In recent weeks, there have been numerous negative developments in the disposable e-cigarette market in the United Kingdom. Independent laboratory Inter scientific reported that 73% of tested e-cigarette liquids exceeded capacity standards and that none of the tested products were registered on the MHRA's list. The UK's Minister of Health and Prime Minister spoke out, pledging to enforce regulations on illegal e-cigarettes and to crack down specifically on underage use of e-cigarettes.


On April 26th at 18:00 Beijing time, 2FIRSTS conducted a live video interview with representatives from the UK Vaping Industry Association (UKVIA) and the Independent British Vaping Trade Association (IBVTA), discussing the recent government regulations and changes in the electronic cigarette market in the United Kingdom.


During a one-hour live broadcast, 2FIRSTS discussed compliance standards and manufacturer concerns in the UK electronic cigarette market through a live dialogue.


John, the chairman of UKVIA, has stated that 40% of smokers in the United Kingdom are transitioning to using e-cigarettes. However, recent events may lead the government to consider changing existing regulations in order to ensure greater safety for the public.


When discussing the priorities of UKVIA and IBVTA, John stated that UKVIA is collaborating with the government and actively planning events to facilitate the spread of scientific knowledge.


According to his knowledge, the World Health Organization (WHO) is planning to propose a ban on open systems at a conference (COP 10) in November of this year.


John stated that the association is still facing challenges and will continue to compete with the anti-e-cigarette association.


2FIRSTS will bring more live interpretation reports tomorrow. Stay tuned.


Live streaming footage from 2FIRSTS | Image source: 2FIRSTS


Further Reading:


The Financial Times reports that the issue of electronic cigarette liquid exceeding safety standards in the UK has garnered attention from society. The focus is now on the disputed future regulatory model.


The UK Prime Minister guarantees crackdown on e-cigarette sales featuring excessive e-liquid content and condemns e-cigarette advertising targeting underage individuals.


Over 30,000 illegal tobacco products and e-cigarette oil that surpass safety limits were seized in Staffordshire, United Kingdom.


The Guardian reports that 73% of e-cigarette liquids in the UK exceed regulation limits, with eight zero-nicotine products containing nicotine detected in testing.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
2Firsts Investigation | China–U.S. E-cigarette Shipping Costs Surge: Sea Freight Up Over 200%, Air Cargo Inspection Rate Exceeds 50%
2Firsts Investigation | China–U.S. E-cigarette Shipping Costs Surge: Sea Freight Up Over 200%, Air Cargo Inspection Rate Exceeds 50%
Since late July, China–U.S. e-cigarette shipping costs have surged — sea freight up over 200%, air cargo inspection rates exceeding 50%. 2Firsts investigates the key drivers behind the spike and how the industry is responding.
Oct.15
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Alfabet Labs, the parent company of FLONQ, has recently launched its new vaping brand ROQY in Russia, debuting two products: ROQY L and ROQY M. Both devices use a hybrid nicotine formulation combining nicotine salts and freebase nicotine and are each available in 19 flavors. The two products are now on sale via the official ROQY website as well as multiple online and offline retailers across Russia.
Nov.19 by 2FIRSTS.ai